Neuromuscular Disease News and Research

RSS
Medication used to treat heart arrhythmias also reduces myotonic dystrophy: Researchers

Medication used to treat heart arrhythmias also reduces myotonic dystrophy: Researchers

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

New therapeutic approach for Duchenne muscular dystrophy

New therapeutic approach for Duchenne muscular dystrophy

MDA awards over $21M in grants for advancing critical neuromuscular research

MDA awards over $21M in grants for advancing critical neuromuscular research

RXi Pharmaceuticals, miRagen Therapeutics enter into research collaboration

RXi Pharmaceuticals, miRagen Therapeutics enter into research collaboration

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

MDA awards 42 medical researchers and labs over $21M for critical neuromuscular research

MDA awards 42 medical researchers and labs over $21M for critical neuromuscular research

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Women riders support MDA's initiative on neuromuscular disease

Women riders support MDA's initiative on neuromuscular disease

PTC Therapeutics initiates additional clinical trial of ataluren in boys and young men with nmDBMD

PTC Therapeutics initiates additional clinical trial of ataluren in boys and young men with nmDBMD

microRNA-206 plays crucial role in the progression of ALS

microRNA-206 plays crucial role in the progression of ALS

Non-clinical data of CK-2017357 presented by Cytokinetics

Non-clinical data of CK-2017357 presented by Cytokinetics

Myasthenia Gravis Alliance receives Global Pharmaceuticals grant to further research and awareness

Myasthenia Gravis Alliance receives Global Pharmaceuticals grant to further research and awareness

UT physicians treat Iraqi girl with myasthenia gravis

UT physicians treat Iraqi girl with myasthenia gravis

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease

CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease